Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin Disorders
Chiara Sabbadin(University of Padua), Decio Armanini(University of Padua), Gloria Orlando(University of Padua), Luciana Bordin(University of Padua), Filippo Ceccato(University of Padua), Eugenio Ragazzi(University of Padua), Carlotta Keiko Vedolin(University of Padua), Gabriella Donà(University of Padua), Anna Belloni Fortina(University of Padua), Alessandra Andrisani(University of Padua), Francesca Beggiao(University of Padua), Carla Scaroni(University of Padua), Mattia Barbot(University of Padua)
Cited by 7
Related Papers
Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study
|Journal of Investigative Dermatology|2005|644
Consensus on diagnosis and management of Cushing's disease: a guideline update
|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2021|351
Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients
|Journal of the European Academy of Dermatology and Venereology|2020|248
Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial
|Arthritis & Rheumatism|2011|216